Remove Events Remove Immunization Remove Inpatient
article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

And then into the outpatient and inpatient settings—are we treating the right patients in the inpatient setting that need to be treated? Then we filter that all the way down into the clinic, about how do we, you know, move patients in and out of the system? How are we advanced prepping drugs? Are we making sure things are going well?

article thumbnail

Pharmacists Bridge the Gaps in Care Transitions

Pharmacy Times

Pharmacist-driven programs improve medication adherence and lower healthcare costs, with initiatives like standardized reconciliation models and telehealth services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

Treatment-related adverse events (AEs) included nausea (77.8% Baseline disease characteristics included stage IV disease in 89% (TN) and 95% (R/R) of patients, high-risk Mantle Cell Lymphoma International Prognostic Index scores in 11% and 15%, bulky disease over 5 cm in 17% and 30%, and blastoid morphology in 6% and 15%, respectively.

article thumbnail

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Pharmacy Times

1 Population cohorts included adults ages 65 or older enrolled in Medicare and adults ages 19 to 64 years enrolled in Medicaid and deemed eligible for pneumococcal vaccination based on Advisory Committee on Immunization Practices recommendations. 1 Medicare enrollees were examined first.

article thumbnail

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Pharmacy Times

Finerenone, a nonsteroidal MRA, shows promise in reducing HF events and atrial fibrillation, offering potential benefits over steroidal MRAs like spironolactone. Barriers to finerenone integration include cost, access, and existing MRA underutilization, with pharmacists crucial in educating prescribers and patients.

article thumbnail

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

Among the 37 practices that reported waste, 768 events were reported, leading to a total drug waste of $11,275,642.16. Medically integrated pharmacy (MIP) interventions using data from a cost avoidance and waste tracker tool show: The net cost avoidance for the MIPs was $6,510,971.28 compared with $546,082.45 Of that, $8,935,612.15

article thumbnail

Atrium Health: Pioneering Outpatient Transplant Models Driven by Pharmacist-Led Care

Pharmacy Times

So if patients are doing research about transplants, what they read and hear on the internet is that it’s all inpatient. As I said, if you read anywhere—especially, we've been doing this for 10 years now—it’s hard to believe there weren’t a lot of institutions doing outpatient transplants. And so they're like, “What do you mean?”